47th Annual Convention; Online; 2021
All times listed are Eastern time (GMT-4 at the time of the convention in May).
Event Details
Previous Page
|
Behavioral Pharmacology, Autism, and Comorbidities: The Role of the Applied Behavior Analysis Practitioner |
Sunday, May 30, 2021 |
3:00 PM–3:50 PM |
Online |
Area: BPN/AUT; Domain: Translational |
CE Instructor: Carlos Zuluaga, M.S. |
Chair: Carlos Zuluaga (ABA Technologies, Inc. and Florida Institute of Technology) |
AMANDA BUENO DOS SANTOS (CEDIN, Florida Institute of Technology) |
THOMAS R. FREEMAN (ABA Technologies Inc. - Florida Tech) |
MICHAEL CRIPE (Agency for Persons With Disabilities-State of Florida) |
Abstract: When behavioral services are utilized to reduce problem behavior, psychotropic medication is also often prescribed by attending physicians. When a comorbidity is present, coordinating services between disciplines can present special challenges. This presentation will describe the need to reduce confounds between different treatment modalities, and present some techniques to reduce those confounds while evaluating and promoting ongoing treatment effectiveness. We will review several of the medications that are most commonly used to address problem behavior, describe some of the most common side effects as well as secondary behavioral effects that can impact treatment planning and documentation. We will discuss some common symptoms of various comorbidities, list steps for data collection, and suggest techniques on how to most effectively report and utilize data in coordination with both medical and non-medical professionals. Finally we will discuss the ethical requirement to closely coordinate ABA and medical services, and explore some of the related issues that are likely to arise in clinical practice. |
Instruction Level: Intermediate |
Target Audience: The target audience should have as prerequisite skills knowledge autism spectrum disorder, behavioral service delivery, and behavior intervention plan. |
Learning Objectives: At the conclusion of the presentation, participants will be able to: (1) recognize some common symptoms of various autism spectrum disorder comorbidities, list steps for data collection, and suggest techniques on how to effectively report and utilize data in coordination with both medical and non-medical professionals; (2)know medications that are most commonly used to address problem behavior, describe some of the most common side effects as well as secondary behavioral effects that can impact treatment planning and documentation; (3) how to address ethical requirements to closely coordinate ABA and medical services, and explore some of the related issues that are likely to arise in clinical practice. |
|
|
BACK TO THE TOP
Back to Top